From clinical cancer research: Rethinking Therapeutic Cancer Vaccine Trials Ongoing therapeutic cancer vaccine trials have yet to show evidence of vaccines spurring a patient's immune system to shrink tumors -- yet patients who receive these vaccines in trials tend to live longer and respond better to subsequent treatment. In the July 1 issue of Clinical [...]
Imagine taking a drug that circulates in your body until it finds your cancer. Once a cancer cell is found it directly attacks the cell by delivering radiation directly into the cell. The cancer cell is destroyed with minimal collateral damage to your healthy normal cells! If you suffer from the hard to treat lymphoma, [...]
Cancer Care is sponsoring a telephone workshop to present to the community an update on the recent ASCO proceedings. There is no charge to listen into the workshop. These workshops are geared to the survivor and their families. To sign up for this Telephone Education Workshop click here. Topic: Cancer Type Cancer Type: Prostate Cancer [...]
There is great news for those of us who are on a hormone blockade. The latest reported from the 2007 meeting of the American Society of Clinical Oncology says that Intermittent Androgen Suppression (IAS) is just as effective as continuous therapy. The study cited was a randomized multi-center trial with men diagnosed with advanced prostate [...]
Spectrum Pharmaceuticals announces that the FDA's Oncology Drug Advisory Committee (ODAC) will review their very promising investigational drug Satraplatin for the Treatment of Hormone Refractory Prostate Cancer. The hearing will be held on July 24, 2007. This is very exciting, especially in light of the FDA’s surprising failure to approve Provenge. A quick review of [...]